Window to optimise HIV-1 therapy

17/01/2012 Dr Edwina Wright, an infectious diseases physician and clinical researcher in the Department of Infectious Diseases at Monash and at The Alfred with a program at The Burnet, had an article published in the New England Journal of Medicine. Patients who are started on antiretroviral therapy for HIV-1 infection within four months of estimated infection date — and who have higher counts of CD4+ T-cells at the initiation of therapy — demonstrate a stronger recovery of CD4+ T-cell counts than patients in whom therapy is started later.
The study offers insight into the optimal timing of therapy. (see NEJM article link) and Monash story www.monash.edu.au/news/show/early-therapy-for-hiv-vital.